The “Iowa Get Screened” Colon Cancer Screening Program

Journal of Primary Care & Community Health

Volumn 1, Issue 1, 2010, Pages 43-49

  Levy, Barcey T ^a,b   Daly, Jeanette M ^a   Luxon, Bruce ^a,b   Merchant, Mary L ^a   xu, Yinghui ^a   Levitz, Carly E ^a   Wilbur, Jason K ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

adenomatous polyp; colorectal cancer screening; fecal immunochemical testing; prevention; recruitment strategies; screening program; tubular adenoma; underinsured; uninsured

Indexed keywords

EID: 84990341300     PISSN: 21501319     EISSN: 21501327     Source Type: Journal    
DOI: 10.1177/2150131909352191     Document Type: Article

References (43)

1. Centers for Disease Control and Prevention (CDC). Use of colorectal cancer tests–United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep. 2008;57:253-258.
2. McFarland EG Levin B Lieberman DA. Revised colorectal screening guidelines: joint effort of the American Cancer Society, U.S. Multisociety Task Force on Colorectal Cancer, and American College of Radiology. Radiology. 2008;248:717-720.
3. Winawer SJ Zauber AG Ho MN. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977-1981.
4. Levy BT Joshi M Xu Y Daly J James PA. Perceptions of Iowa family physicians regarding colorectal cancer screening. Med Care. 2008;46(9 Suppl 1):S103-108.
5. Smith RA Cokkinides V Eyre HJ. Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin. 2007;57:90-104.
6. Yeazel M Church TR Jones RM. Colorectal cancer screening adherence in a general population. Cancer Epidemiol Biomarkers Prev. 2004;13:654-657.
7. Levy BT Dawson J Hartz AJ James PA. Colorectal cancer testing among patients cared for by Iowa family physicians. Am J Prev Med. 2006;31:193-201.
8. Liang SY Phillips KA Nagamine M Ladabaum U Haas JS. Rates and predictors of colorectal cancer screening. Prev Chronic Dis. 2006;3:A117.
9. Trivers KF Shaw KM Sabatino SA Shapiro JA Coates RJ. Trends in colorectal cancer screening disparities in people aged 50-64 years, 2000-2005. Am J Prev Med. 2008;35:185-193.
10. Swan J Breen N Coates RJ Rimer BK Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003;97:1528-1540.
11. Shapiro JA Seeff LC Thompson TD Nadel MR Klabunde CN Vernon SW. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2008;17:1623-1630.
12. Ward E Halpern M Schrag N. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008;58:9-31.
13. Robinson JM Shavers V. The role of health insurance coverage in cancer screening utilization. J Health Care Poor Underserved. 2008;19:842-856.
14. Roetzheim RG Pal N Tennant C. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst. 1999;91:1409-1415.
15. Gornick ME Eggers PW Riley GF. Associations of race, education, and patterns of preventive service use with stage of cancer at time of diagnosis. Health Serv Res. 2004;39:1403-1427.
16. Cairns CP Viswanath K. Communication and colorectal cancer screening among the uninsured: data from the Health Information National Trends Survey (United States). Cancer Causes Control. 2006;17:1115-1125.
17. Zauber AG Lansdorp-Vogelaar I Knudsen AB Wilschut J van Ballegooijen M Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:659-669.
18. Fenton JJ Cai Y Green P Beckett LA Franks P Baldwin LM. Trends in colorectal cancer testing among Medicare subpopulations. Am J Prev Med. 2008;35:194-202.
19. Smith RA Cokkinides V Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2009;59:27-41.
20. Levin B Lieberman DA McFarland B. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570-1595.
21. Dillman DA. Mail and Internet Surveys: The Tailored Design Method. Hoboken, NJ: John Wiley & Sons; 2000.
22. van Rossum LG van Rijn AF Laheij RJ. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135:82-90.
23. Morikawa T Kato J Yamaji Y. Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas. Am J Gastroenterol. 2007;102:2259-2264.
24. Lohsiriwat V Thavichaigarn P Awapittaya B. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection. J Med Assoc Thai. 2007;90:2291-2295.
25. Smith A Young GP Cole SR Bampton P. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer. 2006;107:2152-2159.
26. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:627-637.
27. Beydoun HA Beydoun MA. Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States. Cancer Causes Control. 2008;19:339-359.
28. Matthews BA Anderson RC Nattinger AB. Colorectal cancer screening behavior and health insurance status (United States). Cancer Causes Control. 2005;16:735-742.
29. DeNavas-Walt C Proctor BD Smith JC. U.S. Census Bureau, Current Population Reports, P60-235, Income, Poverty, and Health Insurance Coverage in the United States: 2007, U.S. Government Printing Office, Washington, DC, 2008. Available at: http://www.census.gov/prod/2008pubs/p60-235.pdf. Accessed July 2, 2009.
30. Dancourt V Lejeune C Lepage C Gailliard MC Meny B Faivre J. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Eur J Cancer. 2008;44:2254-2258.
31. Quintero E Gimeno-Garcia AZ Parra-Blanco A. One-time screening with an immunochromatographic occult blood test predicts the detection of advanced adenoma and colorectal cancer in the average-risk popluation. Can J Gastroenterol. 2005;19 (Suppl B):21B.
32. Hundt S Haug U Brenner H. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med. 2009;150:162-169.
33. Almog R Ezra G Lavi I Rennert G Hagoel L. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening. Eur J Cancer Prev. 2008;17:430-437.
34. DeBourcy AC Lichtenberger S Felton S Butterfield KT Ahnen DJ Denberg TD. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med. 2008;23:169-174.
35. Young GP St John DJ Winawer SJ Rozen P, WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy). Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol. 2002;97:2499-2507.
36. Institute for Clinical Systems Improvement. Health Care Guideline: Colorectal Cancer Screening. Colorectal Cancer Screening Guideline Web site. Available at: http://www.icsi.org/colorectal_cancer_screening/colorectal_cancer_screening_5.html. Updated 2008. Accessed June 9, 2009.
37. Allison JE Sakoda LC Levin TR. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007;99 :1462-1470.
38. Levi Z Rozen P Hazazi R. Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants. Am J Gastroenterol. 2009;104:933-938.
39. Mandelson MT Curry SJ Anderson LA. Colorectal cancer screening participation by older women. Am J Prev Med. 2000;19:149-154.
40. Hiatt RA Perez-Stable EJ Quesenberry C Jr Sabogal F Otero-Sabogal R McPhee SJ. Agreement between self-reported early cancer detection practices and medical audits among Hispanic and non-Hispanic white health plan members in northern California. Prev Med. 1995;24:278-285.
41. Daly JM Levy BT Joshi M Xu Y Jogerst GJ. Patient clock drawing and accuracy of self-report compared with chart review for colorectal cancer (CRC) screening. Arch Gerontol Geriatr. June 30, 2009. [Epub ahead of print.
42. Fisher D Jeffreys A Coffman C Fasanella K. Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiology, Biomarkers & Prevention. 2006;15:1232-1235.
43. Denberg TD Melhado TV Coombes JM. Predictors of nonadherence to screening colonoscopy. J Gen Intern Med. 2005;20:989-995.